Segment | Group A | Group B | Group C | Group D | p-value of ANOVA |
---|---|---|---|---|---|
Age [years] | 12.3 ± 4.9 | 14.7 ± 8.4 | 14.5 ± 4.8 | 14.9 ± 2.6 | 0.72 |
LV EF [%] | 64.9 ± 7.3 | 63.5 ± 10.7 | 58.3 ± 13.7 | 46.0 ± 16.6 | 0.092 |
LVMi [g/m2] | 37.8 ± 4.8 | 37.2 ± 10.9 | 38.9 ± 15.2 | 46.9 ± 7.5 | 0.60 |
LV EDVi [ml/m 2 ] | 52 (49–55) | 56 (43–64) | 48 (36–63) | 61 (48–72) | 0.87 |
LV ESVi [ml/m 2 ] | 18 (13–21) | 21 (12–29) | 16 (14–27) | 35 (20–53) | 0.42 |
LV SVi [ml/m 2 ] | 31 (30–38) | 34 (30–35) | 29 (25–35) | 26 (17–28) | 0.13 |
Native T1 (anterior) | 1029 ± 31 | 1082 ± 77 | 1067 ± 65 | 1045 ± 16 | 0.31 |
Native T1 (anteroseptal) | 1029 ± 28 | 1052 ± 41 | 1032 ± 31 | 1036 ± 9 | 0.62 |
Native T1 (inferoseptal) | 1029 ± 25 | 1054 ± 55 | 1033 ± 40 | 1059 ± 32 | 0.29 |
Native T1 (inferior) | 1031 ± 32 | 1050 ± 44 | 1046 ± 58 | 1041 ± 35 | 0.88 |
Native T1 (inferolateral) | 1040 ± 39 | 1037 ± 42 | 1057 ± 33 | 1058 ± 52 | 0.65 |
Native T1 (anterolateral) | 1016 ± 38 | 1013 ± 36 | 1052 ± 68 | 1027 ± 43 | 0.38 |
Native T1 (global) | 1029 ± 28 | 1049 ± 37 | 1047 ± 39 | 1045 ± 20 | 0.62 |
ECV (anterior) | 0.262 ± 0.020 | 0.261 ± 0.013 | 0.269 ± 0.050 | 0.263 ± 0.039 | 0.97 |
ECV (anteroseptal) | 0.255 ± 0.037 | 0.247 ± 0.019 | 0.259 ± 0.036 | 0.306 ± 0.103 | 0.28 |
ECV (inferoseptal)* | 0.248 ± 0.031 | 0.237 ± 0.009 | 0.252 ± 0.036 | 0.321 ± 0.066 a.b | 0.010 |
ECV (inferior) | 0.250 ± 0.032 | 0.243 ± 0.008 | 0.265 ± 0.043 | 0.274 ± 0.031 | 0.53 |
ECV (inferolateral)* | 0.256 ± 0.049 | 0.256 ± 0.045 | 0.293 ± 0.067 | 0.391 ± 0.116 a,b | 0.022 |
ECV (anterolateral) | 0.250 ± 0.040 | 0.253 ± 0.016 | 0.276 ± 0.048 | 0.344 ± 0.117 | 0.070 |
ECV (global) | 0.253 ± 0.032 | 0.249 ± 0.008 | 0.269 ± 0.043 | 0.304 ± 0.047 | 0.17 |